{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:34:13Z","timestamp":1792798453414,"version":"4.5.0"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01520","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T04:36:31Z","timestamp":1546835791000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":67,"title":["Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application"],"prefix":"10.3389","volume":"9","author":[{"given":"Yandong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sili","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev.immunol.14.1.483","article-title":"Immunopharmacology of rapamycin.","volume":"14","author":"Abraham","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.2174\/138161210794454923","article-title":"Sirolimusand its analogs and its effects on vascular diseases.","volume":"16","author":"Adelman","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1093\/eurheartj\/eht532","article-title":"Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo.","volume":"35","author":"Akhmedov","year":"2014","journal-title":"Eur. Heart J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","article-title":"Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.","volume":"129","author":"Allahverdian","year":"2014","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl296","article-title":"Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients.","author":"Andres","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1016\/j.transproceed.2003.10.050","article-title":"Effect of sirolimus on the cholesterol content of aortic arch in ApoE knockout mice.","volume":"35","author":"Basso","year":"2003","journal-title":"Transplant. Proc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American heart association.","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis.","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk.","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacc.2008.11.029","article-title":"A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (stenting of saphenous vein grafts) trial.","volume":"53","author":"Brilakis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2003.09.003","article-title":"Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a P27 Kip1 -independent pathway.","volume":"172","author":"Castro","year":"2004","journal-title":"Atherosclerosis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbrc.2009.03.040","article-title":"FGFR1 forms an FRS2-dependent complex with mTOR to regulate smooth muscle marker gene expression.","volume":"382","author":"Chen","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1476-5381.2008.00102.x","article-title":"Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels.","volume":"156","author":"Chen","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/cvr\/cvm103","article-title":"Rapamycin modulates the enos vs. Shear stress relationship.","volume":"78","author":"Cheng","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","article-title":"Allograft vasculopathy: the achilles\u2019 heel of heart transplantation.","volume":"68","author":"Chih","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0735-1097(02)02598-6","article-title":"Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment.","volume":"40","author":"Chung","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nm1459","article-title":"Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.","volume":"12","author":"Clarke","year":"2006","journal-title":"Nat. Med."},{"key":"B18","first-page":"623","article-title":"Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.","volume":"27","author":"Cowan","year":"2000","journal-title":"Nephrol. Nurs. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1161\/CIRCRESAHA.116.303804","article-title":"Autophagy in vascular disease.","volume":"116","author":"De Meyer","year":"2015","journal-title":"Circ. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance.","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2005.08.016","article-title":"Countervailing effects of rapamycin (sirolimus) on nuclear factor-kappa b activities in neointimal and medial smooth muscle cells.","volume":"186","author":"Dichtl","year":"2006","journal-title":"Atherosclerosis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/ATVBAHA.110.216804","article-title":"Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FOXO4.","volume":"31","author":"Ding","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jconrel.2016.05.049","article-title":"Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice.","volume":"235","author":"Dou","year":"2016","journal-title":"J. Control. Release"},{"key":"B25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1583\/05-1704.1","article-title":"Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the sirocco trial.","volume":"13","author":"Duda","year":"2006","journal-title":"J. Endovasc. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/01.CIR.0000029746.10018.36","article-title":"Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.","volume":"106","author":"Duda","year":"2002","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0024-3205(95)02233-3","article-title":"Mechanism of action of the immunosuppressant rapamycin.","volume":"58","author":"Dumont","year":"1996","journal-title":"Life Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1034\/j.1600-6143.2003.00094.x","article-title":"Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in APO E-deficient mice.","volume":"3","author":"Elloso","year":"2003","journal-title":"Am. J. Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/s00330-008-1225-1","article-title":"The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries.","volume":"19","author":"Falkowski","year":"2009","journal-title":"Eur. Radiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1161\/01.CIR.0000139337.56084.30","article-title":"Extracellular matrix changes in stented human coronary arteries.","volume":"110","author":"Farb","year":"2004","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1172\/JCI38911","article-title":"LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.","volume":"120","author":"Feig","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.bbalip.2014.03.014","article-title":"Inhibition of mtor down-regulates scavenger receptor, class b, type I (SR-BI) expression, reduces endothelial cell migration and impairs nitric oxide production.","volume":"1841","author":"Fruhwurth","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2017.07.016","article-title":"Drug-eluting embolic microspheres for local drug delivery - state of the art.","volume":"262","author":"Fuchs","year":"2017","journal-title":"J. Control. Release"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1590\/S0100-879X2009005000036","article-title":"Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice.","volume":"42","author":"Gadioli","year":"2009","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3322\/canjclin.57.2.112","article-title":"Recent progress in the management of advanced renal cell carcinoma.","volume":"57","author":"Garcia","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/ATVBAHA.115.305896","article-title":"Senescent vascular smooth muscle cells drive inflammation through an interleukin-1alpha-dependent senescence-associated secretory phenotype.","volume":"35","author":"Gardner","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jacc.2004.08.064","article-title":"Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a department of veterans affairs cooperative study.","volume":"44","author":"Goldman","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2006.11.023","article-title":"Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM.","volume":"195","author":"Goueffic","year":"2007","journal-title":"Atherosclerosis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7687083","article-title":"Defective autophagy in atherosclerosis: to die or to senesce?","volume":"2018","author":"Grootaert","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1007\/s10439-014-1033-5","article-title":"Autophagy regulates vascular endothelial cell enos and ET-1 expression induced by laminar shear stress in an ex vivo perfused system.","volume":"42","author":"Guo","year":"2014","journal-title":"Ann. Biomed. Eng."},{"key":"B41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.atherosclerosis.2005.12.031","article-title":"Sirolimus accelerates senescence of endothelial progenitor cells through telomerase inactivation.","volume":"189","author":"Imanishi","year":"2006","journal-title":"Atherosclerosis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1253\/circj.CJ-09-0343","article-title":"Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation.","volume":"73","author":"Ino","year":"2009","journal-title":"Circ. J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cmet.2008.08.013","article-title":"Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia.","volume":"8","author":"Jung","year":"2008","journal-title":"Cell. Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The rapamune us study group.","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/00007890-199810270-00013","article-title":"Immunosuppressive effects and safety of a sirolimus\/cyclosporine combination regimen for renal transplantation.","volume":"66","author":"Kahan","year":"1998","journal-title":"Transplantation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1073\/pnas.070046397","article-title":"Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.","volume":"97","author":"Kalka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jcin.2015.10.038","article-title":"Wound healing outcomes and health-related quality-of-life changes in the achilles trial: 1-year results from a prospective randomized controlled trial of infrapopliteal balloon angioplasty versus sirolimus-eluting stenting in patients with ischemic peripheral arterial disease.","volume":"9","author":"Katsanos","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/1535370217693116","article-title":"Targeting cell adhesion molecules with nanoparticles using in vivo and flow-based in vitro models of atherosclerosis.","volume":"242","author":"Khodabandehlou","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1007\/s10439-015-1315-6","article-title":"Reducing neointima formation in a swine model with IVUS and sirolimus microbubbles.","volume":"43","author":"Kilroy","year":"2015","journal-title":"Ann. Biomed. Eng."},{"key":"B51","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1399-0012.2004.00253.x","article-title":"Dyslipidemia during sirolimus therapy in patients after liver transplantation.","volume":"18","author":"Kniepeiss","year":"2004","journal-title":"Clin. Transplant."},{"key":"B52","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1172\/JCI21767","article-title":"T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of no synthase.","volume":"114","author":"Koh","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/01.RES.0000119804.92239.97","article-title":"Apoptosis of vascular cells by oxidized LDL: Involvement of caspases and LOX-1 and its implication in atherosclerotic plaque rupture.","volume":"94","author":"Kume","year":"2004","journal-title":"Circ. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1152\/physrev.00003.2017","article-title":"Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease.","volume":"97","author":"Lacolley","year":"2017","journal-title":"Physiol. Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.amjcard.2010.03.030","article-title":"Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter southern California registry).","volume":"106","author":"Lee","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000119199","article-title":"Mtor inhibitors and calcineurin inhibitors do not affect adhesion molecule expression of human macro- and microvascular endothelial cells.","volume":"45","author":"Lehle","year":"2008","journal-title":"J. Vasc. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/1755-5922.12159","article-title":"Metallic limus-eluting stents abluminally coated with biodegradable polymers: angiographic and clinical comparison of a novel ultra-thin sirolimus stent versus biolimus stent in the destiny randomized trial.","volume":"33","author":"Lemos","year":"2015","journal-title":"Cardiovasc. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature09782","article-title":"Autophagy in immunity and inflammation.","volume":"469","author":"Levine","year":"2011","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cmet.2012.01.022","article-title":"Macrophage autophagy plays a protective role in advanced atherosclerosis.","volume":"15","author":"Liao","year":"2012","journal-title":"Cell Metab."},{"key":"B60","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1172\/JCI119528","article-title":"Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class a type I\/II gene.","volume":"100","author":"Ling","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00469","article-title":"Chinese herbal medicine on cardiovascular diseases and the mechanisms of action.","volume":"7","author":"Liu","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-016-0274-z","article-title":"Autophagy is associated with cell fate in the process of macrophage-derived foam cells formation and progress.","volume":"23","author":"Liu","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00692","article-title":"Luteolin: a flavonoid that has multiple cardio-protective effects and its molecular mechanisms.","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3018190","article-title":"Moderate autophagy inhibits vascular smooth muscle cell senescence to stabilize progressed atherosclerotic plaque via the mtorc1\/ULK1\/Atg13 signal pathway.","volume":"2017","author":"Luo","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.intimp.2017.02.026","article-title":"Expression of miRNA-155 in carotid atherosclerotic plaques of apolipoprotein E knockout (APoE(-\/-)) mice and the interventional effect of rapamycin.","volume":"46","author":"Ma","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"H2721","DOI":"10.1152\/ajpheart.01174.2006","article-title":"Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells.","volume":"292","author":"Ma","year":"2007","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"H1646","DOI":"10.1152\/ajpheart.00492.2009","article-title":"Sirolimus inhibits endogenous cholesterol synthesis induced by inflammatory stress in human vascular smooth muscle cells.","volume":"298","author":"Ma","year":"2010","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"C507","DOI":"10.1152\/ajpcell.00201.2003","article-title":"The mtor\/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation.","volume":"286","author":"Martin","year":"2004","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jps.20751","article-title":"The pharmacodynamic effects of sirolimus and sirolimus-calcineurin inhibitor combinations on macrophage scavenger and nuclear hormone receptors.","volume":"96","author":"Mathis","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3892\/etm.2015.2201","article-title":"Preparation of a liposomal delivery system and its in vitro release of rapamycin.","volume":"9","author":"Miao","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1194\/jlr.R039479","article-title":"Regulation of signal transduction by HDL.","volume":"54","author":"Mineo","year":"2013","journal-title":"J. Lipid Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"E184","DOI":"10.1002\/ccd.24844","article-title":"Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: the credential study.","volume":"82","author":"Mischie","year":"2013","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.","volume":"346","author":"Morice","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.yjmcc.2011.06.010","article-title":"Autophagy as a therapeutic target in cardiovascular disease.","volume":"51","author":"Nemchenko","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.atherosclerosis.2014.01.036","article-title":"Advances in mechanisms, imaging and management of the unstable plaque.","volume":"233","author":"Niccoli","year":"2014","journal-title":"Atherosclerosis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0006-291X(02)02965-0","article-title":"Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells.","volume":"301","author":"Ohkawa","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B77","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1160\/TH04-10-0661","article-title":"Modulation of tissue factor expression by rapamycin and FK-506 in lipopolysaccharide-stimulated human mononuclear cells and serum-stimulated aortic smooth muscle cells.","volume":"94","author":"Ollivier","year":"2005","journal-title":"Thromb. Haemost."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","article-title":"Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment.","volume":"36","author":"Otsuka","year":"2015","journal-title":"Eur. Heart J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/01.fjc.0000177985.14305.15","article-title":"Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis.","volume":"46","author":"Pakala","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B80","first-page":"1307","article-title":"Folic acid inhibits dedifferentiation of PDGF-BB-induced vascular smooth muscle cells by suppressing mTOR\/P70S6K signaling.","volume":"9","author":"Pan","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.humimm.2011.03.015","article-title":"CD4(+)CD25(high)CD127(low) regulatory T cells in patients with stable angina and their dynamics after intracoronary sirolimus-eluting stent implantation.","volume":"72","author":"Potekhina","year":"2011","journal-title":"Hum. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1161\/CIRCRESAHA.114.301174","article-title":"Mechanisms that regulate macrophage burden in atherosclerosis.","volume":"114","author":"Randolph","year":"2014","journal-title":"Circ. Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial.","volume":"60","author":"Rastan","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1093\/eurheartj\/ehr144","article-title":"Sirolimus-eluting stents vs. Bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial.","volume":"32","author":"Rastan","year":"2011","journal-title":"Eur. Heart J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9995","article-title":"Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis.","volume":"6","author":"Roth","year":"2015","journal-title":"Nat. Commun."},{"key":"B87","first-page":"21","article-title":"Sirolimus, the first mtor inhibitor.","author":"Sanchez-Plumed","year":"2006","journal-title":"Nefrologia"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the achilles trial.","volume":"60","author":"Scheinert","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/CIRCULATIONAHA.113.004149","article-title":"Endothelial junctional adhesion molecule-A guides monocytes into flow-dependent predilection sites of atherosclerosis.","volume":"129","author":"Schmitt","year":"2014","journal-title":"Circulation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7164\/antibiotics.28.727","article-title":"Rapamycin (ay-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.","volume":"28","author":"Sehgal","year":"1975","journal-title":"J. Antibiot."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/j.1523-1755.2005.00224.x","article-title":"Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: results of a controlled pilot study.","volume":"67","author":"Shitrit","year":"2005","journal-title":"Kidney Int."},{"key":"B92","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1002\/jcp.26276","article-title":"Therapeutic potency of mtor signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives.","volume":"233","author":"Soltani","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.","volume":"356","author":"Stone","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/aps.2017.102","article-title":"Rapamycin inhibits ox-LDL-induced inflammation in human endothelial cells in vitro by inhibiting the mTORC2\/PKC\/c-Fos pathway.","volume":"39","author":"Sun","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"B95","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","article-title":"Macrophage phenotype and function in different stages of atherosclerosis.","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ. Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.immuni.2017.09.008","article-title":"Monocyte-macrophages and t cells in atherosclerosis.","volume":"47","author":"Tabas","year":"2017","journal-title":"Immunity"},{"key":"B97","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity.","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3109\/07853890.2013.770333","article-title":"Inhibition of the mtor pathway: a possible protective role in coronary artery disease.","volume":"45","author":"Tarantino","year":"2013","journal-title":"Ann. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00005344-200501000-00014","article-title":"The impact of immunosuppression on endothelial function.","volume":"45","author":"Trapp","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/jlts.2001.23012","article-title":"Liver transplantation using sirolimus and minimal corticosteroids (3-day taper).","volume":"7","author":"Trotter","year":"2001","journal-title":"Liver Transpl."},{"key":"B101","doi-asserted-by":"publisher","first-page":"F43","DOI":"10.1152\/ajprenal.00181.2004","article-title":"Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts.","volume":"289","author":"Varghese","year":"2005","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1084\/jem.20131125","article-title":"Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2.","volume":"211","author":"Wang","year":"2014","journal-title":"J. Exp. Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/CIRCRESAHA.107.151068","article-title":"Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation.","volume":"101","author":"Wang","year":"2007","journal-title":"Circ. Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1583\/11-3665.1","article-title":"Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-up.","volume":"19","author":"Werner","year":"2012","journal-title":"J. Endovasc. Ther."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1093\/eurheartj\/ehw343","article-title":"Ten-year clinical outcomes of first-generation drug-eluting stents: the sirolimus-eluting vs. Paclitaxel-eluting stents for coronary revascularization (SIRTAX) very late trial.","volume":"37","author":"Yamaji","year":"2016","journal-title":"Eur. Heart J."},{"key":"B106","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/ncb0910-814","article-title":"Eaten alive: a history of macroautophagy.","volume":"12","author":"Yang","year":"2010","journal-title":"Nat. Cell. Biol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/abbs\/gmr093","article-title":"Toll-like receptor 4 is up-regulated by mTOR activation during THP-1 macrophage foam cells formation.","volume":"43","author":"Yu","year":"2011","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"B108","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3892\/mmr.2013.1460","article-title":"SIRT1 prevents atherosclerosis via liver-X-receptor and NF-kappab signaling in a U937 cell model.","volume":"8","author":"Zeng","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"B109","doi-asserted-by":"publisher","first-page":"7888","DOI":"10.1074\/jbc.M117.779447","article-title":"AMP-activated protein kinase alpha1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation.","volume":"292","author":"Zhang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B110","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000441143","article-title":"Rapamycin promotes the autophagic degradation of oxidized low-density lipoprotein in human umbilical vein endothelial cells.","volume":"52","author":"Zhang","year":"2015","journal-title":"J. Vasc. Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.bbrc.2010.03.026","article-title":"The autophagy-lysosome pathway: a novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells.","volume":"394","author":"Zhang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1476-5381.2008.00080.x","article-title":"Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor.","volume":"156","author":"Zhao","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3892\/mmr.2017.7032","article-title":"mTOR signaling promotes foam cell formation and inhibits foam cell egress through suppressing the SIRT1 signaling pathway.","volume":"16","author":"Zheng","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146777","article-title":"Rapamycin inhibits oxidized low density lipoprotein uptake in human umbilical vein endothelial cells via mTOR\/NF-kappab\/lox-1 pathway.","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01520\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T04:37:11Z","timestamp":1546835831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01520\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":114,"alternative-id":["10.3389\/fphar.2018.01520"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01520","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"article-number":"1520"}}